Children’s National Medical Center to Investigate Diabetes Genetic Markers with OpenArray™ System
News Jan 17, 2008
BioTrove, Inc. has announced that researchers at the Children’s National Medical Center will use the BioTrove OpenArray™ SNP genotyping system to examine genes for diabetes-related traits, as well as to investigate genetic variants affecting skeletal muscle hypertrophy – the build-up of skeletal muscle tissue – with resistance training in multiple large populations.
“Research takes time and persistence to ensure accurate data, and when it comes to our young patients, we are seeking to speed up the clock while understanding how we can help. Children’s National is committed to finding innovative ways to address diseases affecting these young patients – including research into genetic indicators for certain conditions,” said Joseph Devany, Ph.D., assistant professor and head of the Genotyping Lab in the Research Center for Genetic Medicine at Children’s National Medical Center.
“Comparing thousands of samples across large populations would take several years with conventional methods. The high-throughput OpenArray system enables us to process samples in weeks instead of years, and its high accuracy helps conduct in-depth research without depleting our precious DNA samples,” said Eric Hoffman, Ph.D., Clark Professor of Pediatrics and director of the Research Center for Genetic Medicine at Children’s National.
"Non-Gene" Mutations May Hold Answers to Neurodevelopmental DisordersNews
Mutations in non-coding regions of the genome, which don't contain genes, but control the regulation of other genes, may hold answers to rare developmental disorders that affect the nervous system.READ MORE
Majority of European Wolves Have Dog DNANews
The wolf may not often act like man's best friend, but a new study has found that the majority of wild wolves in Europe contain chunks of dog DNA. The finding is causing scientists to rethink what constitutes a wolfdog hybrid and how we approach conservation of keystone wolf populations.READ MORE
Neuroblastoma Biomarker Research Advances TreatmentNews
Neuroblastoma, a childhood cancer, is treatable in less than half of aggressive cases, but new RNA biomarkers may help identify high-risk patients faster and lead to better prognosis.READ MORE